Scott Krieger has joined Autoscribe Informatics as Director of Technical Services, North America. Scott will be bringing his extensive leadership experience to the organisation, working closely with the Technical Services team to streamline the implementation and support processes at the company.
Autoscribe Informatics has announced the appointment of Jason Jones as technical sales manager in the UK
Autoscribe Informatics will again be exhibiting at the Making Pharmaceuticals event, giving visitors from the pharmaceutical industry the chance to see how the Matrix Gemini LIMS can help streamline business, increase profitability and meet regulatory requirements. On show will be Matrix solutions in the key areas of stability studies and environmental monitoring, as well as the powerful and versatile Matrix Gemini LIMS.
Autoscribe Informatics offers industry leading configurable future-proof LIMS software. With 30 years’ experience our solutions are configured to match user requirements and can easily adapt as needs evolve. Matrix Gemini LIMS (LES, ELN & QMS) allows you to track and manage testing activities within a controlled environment with ease.
Robert Roe investigates the importance of upgrading legacy laboratory informatics systems and the benefits this provides to scientists
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics, featuring flexibility and productivity enhancements, will be on show at Lab Innovations 2016, together with the brand new Environmental Sampling Management module
The Matrix Gemini Laboratory Information Management System (LIMS) from Autoscribe Informatics allows QC laboratories in the dairy industry to accurately record, evaluate and trace test results throughout the production process.
Autoscribe Informatics has annoucned that the latest version of its Matrix Gemini LIMS now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
